476 related articles for article (PubMed ID: 19700204)
21. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
[TBL] [Abstract][Full Text] [Related]
22. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
[TBL] [Abstract][Full Text] [Related]
24. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura.
Rueda B; Perez-Armengol C; Lopez-Lopez S; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
J Rheumatol; 2006 Jan; 33(1):69-73. PubMed ID: 16395752
[TBL] [Abstract][Full Text] [Related]
25. Orosomucoid influences the response to antidepressants in major depressive disorder.
Harley J; Roberts R; Joyce P; Mulder R; Luty S; Frampton C; Kennedy M
J Psychopharmacol; 2010 Apr; 24(4):531-5. PubMed ID: 19395425
[TBL] [Abstract][Full Text] [Related]
26. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
[TBL] [Abstract][Full Text] [Related]
27. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum.
Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C
Hum Mol Genet; 2009 Sep; 18(17):3344-51. PubMed ID: 19483196
[TBL] [Abstract][Full Text] [Related]
29. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
[TBL] [Abstract][Full Text] [Related]
30. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
[TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; W
